PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog ®/NovoRapid® in Healthy Males

Condition:   Diabetes Mellitus, Type 1 Intervention:   Drug: Gan & Lee Insulin Aspart Sponsor:   Gan and Lee Pharmaceuticals, USA Completed

Source: ClinicalTrials.gov - January 23, 2020 Category: Research Source Type: clinical trials